Johannes Bargehr

Johannes Bargehr is a BHF Intermediate Clinical Research Fellow at the University of Cambridge and an honorary cardiology fellow in heart failure at Royal Papworth and Addenbrooke’s hospitals.  He graduated from the University of Innsbruck with a degree in medicine and subsequently completed a PhD degree in the Cambridge Stem Cell Institute with Prof Sanjay Sinha. During his PhD, he spent over a year in the Murry lab at the University of Washington to investigate the regenerative potential of human pluripotent stem cell (hPSC)-derived epicardial cells in myocardial remuscularisation. Following his PhD, Johannes continued to work as a post-doctoral fellow in the Sinha lab, while completing his cardiology clinical training in Cambridge.

Johannes’s research uses immunomodulatory strategies to enhance the efficacy of cardiac cell therapy. He also uses hPSC-derived cardiomyocytes in conjunction with immune cells for disease modelling and drug discovery. He is a co-founder of the biotechnology company ABS Biotechnologies GmbH.